212 related articles for article (PubMed ID: 18305049)
1. pRB-E2F1 complexes are resistant to adenovirus E1A-mediated disruption.
Seifried LA; Talluri S; Cecchini M; Julian LM; Mymryk JS; Dick FA
J Virol; 2008 May; 82(9):4511-20. PubMed ID: 18305049
[TBL] [Abstract][Full Text] [Related]
2. Independent regions of adenovirus E1A are required for binding to and dissociation of E2F-protein complexes.
Fattaey AR; Harlow E; Helin K
Mol Cell Biol; 1993 Dec; 13(12):7267-77. PubMed ID: 8246949
[TBL] [Abstract][Full Text] [Related]
3. Adenovirus E1A directly targets the E2F/DP-1 complex.
Pelka P; Miller MS; Cecchini M; Yousef AF; Bowdish DM; Dick F; Whyte P; Mymryk JS
J Virol; 2011 Sep; 85(17):8841-51. PubMed ID: 21715488
[TBL] [Abstract][Full Text] [Related]
4. Cyclin-dependent kinases phosphorylate the adenovirus E1A protein, enhancing its ability to bind pRb and disrupt pRb-E2F complexes.
Mal A; Piotrkowski A; Harter ML
J Virol; 1996 May; 70(5):2911-21. PubMed ID: 8627766
[TBL] [Abstract][Full Text] [Related]
5. Conserved region 2 of adenovirus E1A has a function distinct from pRb binding required to prevent cell cycle arrest by p16INK4a or p27Kip1.
Alevizopoulos K; Sanchez B; Amati B
Oncogene; 2000 Apr; 19(16):2067-74. PubMed ID: 10803468
[TBL] [Abstract][Full Text] [Related]
6. Interaction of mouse adenovirus type 1 early region 1A protein with cellular proteins pRb and p107.
Smith K; Ying B; Ball AO; Beard CW; Spindler KR
Virology; 1996 Oct; 224(1):184-97. PubMed ID: 8862413
[TBL] [Abstract][Full Text] [Related]
7. pRB, p107 and the regulation of the E2F transcription factor.
Dyson N
J Cell Sci Suppl; 1994; 18():81-7. PubMed ID: 7883798
[TBL] [Abstract][Full Text] [Related]
8. An oncolytic adenovirus selective for retinoblastoma tumor suppressor protein pathway-defective tumors: dependence on E1A, the E2F-1 promoter, and viral replication for selectivity and efficacy.
Jakubczak JL; Ryan P; Gorziglia M; Clarke L; Hawkins LK; Hay C; Huang Y; Kaloss M; Marinov A; Phipps S; Pinkstaff A; Shirley P; Skripchenko Y; Stewart D; Forry-Schaudies S; Hallenbeck PL
Cancer Res; 2003 Apr; 63(7):1490-9. PubMed ID: 12670895
[TBL] [Abstract][Full Text] [Related]
9. E1A 12S and 13S of the transformation-defective adenovirus type 12 strain CS-1 inactivate proteins of the RB family, permitting transactivation of the E2F-dependent promoter.
Pützer BM; Rumpf H; Rega S; Brockmann D; Esche H
J Virol; 1997 Dec; 71(12):9538-48. PubMed ID: 9371617
[TBL] [Abstract][Full Text] [Related]
10. Regulation of adenovirus 12 E1A transcription: E2F and ATF motifs in the E1A promoter bind nuclear protein complexes including E2F1, DP-1, cyclin A and/or RB and mediate transcriptional (auto)activation.
Kirch HC; Pützer B; Schwabe G; Gnauck HK; Schulte Holthausen H
Cell Mol Biol Res; 1993; 39(8):705-16. PubMed ID: 7951410
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of E2F-1 transactivation by direct binding of the retinoblastoma protein.
Helin K; Harlow E; Fattaey A
Mol Cell Biol; 1993 Oct; 13(10):6501-8. PubMed ID: 8413249
[TBL] [Abstract][Full Text] [Related]
12. An E2F dominant negative mutant blocks E1A induced cell cycle progression.
Dobrowolski SF; Stacey DW; Harter ML; Stine JT; Hiebert SW
Oncogene; 1994 Sep; 9(9):2605-12. PubMed ID: 8058324
[TBL] [Abstract][Full Text] [Related]
13. Functional importance of complex formation between the retinoblastoma tumor suppressor family and adenovirus E1A proteins as determined by mutational analysis of E1A conserved region 2.
Corbeil HB; Branton PE
J Virol; 1994 Oct; 68(10):6697-709. PubMed ID: 8084002
[TBL] [Abstract][Full Text] [Related]
14. Mutagenesis of the pRB pocket reveals that cell cycle arrest functions are separable from binding to viral oncoproteins.
Dick FA; Sailhamer E; Dyson NJ
Mol Cell Biol; 2000 May; 20(10):3715-27. PubMed ID: 10779361
[TBL] [Abstract][Full Text] [Related]
15. pRB contains an E2F1-specific binding domain that allows E2F1-induced apoptosis to be regulated separately from other E2F activities.
Dick FA; Dyson N
Mol Cell; 2003 Sep; 12(3):639-49. PubMed ID: 14527410
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional repression by the Rb-related protein p107.
Zamanian M; La Thangue NB
Mol Biol Cell; 1993 Apr; 4(4):389-96. PubMed ID: 7685208
[TBL] [Abstract][Full Text] [Related]
17. Oncogene-induced sensitization to chemotherapy-induced death requires induction as well as deregulation of E2F1.
Helgason GV; O'Prey J; Ryan KM
Cancer Res; 2010 May; 70(10):4074-80. PubMed ID: 20460519
[TBL] [Abstract][Full Text] [Related]
18. Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product.
Chellappan S; Kraus VB; Kroger B; Munger K; Howley PM; Phelps WC; Nevins JR
Proc Natl Acad Sci U S A; 1992 May; 89(10):4549-53. PubMed ID: 1316611
[TBL] [Abstract][Full Text] [Related]
19. A p53-independent apoptotic mechanism of adenoviral mutant E1A was involved in its selective antitumor activity for human cancer.
Fang L; Cheng Q; Zhao J; Ge Y; Zhu Q; Zhao M; Zhang J; Zhang Q; Li L; Liu J; Zheng J
Oncotarget; 2016 Jul; 7(30):48309-48320. PubMed ID: 27340782
[TBL] [Abstract][Full Text] [Related]
20. DNA damage signals through differentially modified E2F1 molecules to induce apoptosis.
Carnevale J; Palander O; Seifried LA; Dick FA
Mol Cell Biol; 2012 Mar; 32(5):900-12. PubMed ID: 22184068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
